J. Hopkins-coronavirus-resource and . Center,

H. J. Larson, Blocking information on COVID-19 can fuel the spread of misinformation, Nature, vol.580, p.306, 2020.

N. F. Johnson, The online competition between pro-and anti-vaccination views

, Nature, 2020.

J. Brainard, Scientists are drowning in COVID-19 papers. Can new tools keep them afloat? Science, 2020.

R. G. White, A. J. Hakim, M. J. Salganik, M. W. Spiller, L. G. Johnston et al.,

C. Kendall, A. Drake, D. Wilson, K. Orroth, M. Egger et al., Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies, J Clin Epidemiol, 2015.

M. Sharma, S. Scarr, and K. Kelland, Speed Science: The risks of swiftly spreading coronavirus research. Reuters, 2020.

B. Trogen, D. Oshinsky, and A. Caplan, Adverse Consequences of Rushing a SARS

, Vaccine: Implications for Public Trust, 2020.

R. Collins and S. Macmahon, Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials, Lancet, vol.357, issue.9253, pp.373-80, 2001.

S. Barton, C. J. Rush, R. T. Campbell, P. S. Jhund, M. C. Petrie et al., Association is not causation: treatment effects cannot be estimated from observational data in heart failure, Eur Heart J, vol.321, issue.7256, pp.3417-3438, 2000.

A. Hackshaw, Small studies: strengths and limitations, Eur Respir J, England, 2008.

M. T. Wang, M. J. Bolland, G. Gamble, A. Grey, and . Media-coverage, Journal Press Releases and Editorials Associated with Randomized and Observational Studies in High-Impact Medical Journals: A Cohort Study, PLoS One, vol.10, issue.12, p.145294, 2015.

J. R. Guertin, E. Rahme, C. R. Dormuth, and J. Lelorier, Head to head comparison of the propensity score and the high-dimensional propensity score matching methods, BMC Med Res Methodol, vol.16, p.22, 2016.

D. B. Rubin, The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials, Stat Med, vol.26, issue.1, pp.20-36, 2007.

R. M. Kaplan, D. A. Chambers, and R. E. Glasgow, Big data and large sample size: a cautionary note on the potential for bias, Clin Transl Sci, vol.7, issue.4, pp.342-348, 2014.

N. Freemantle, L. Marston, K. Walters, J. Wood, M. R. Reynolds et al., Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research, Bmj, p.6409, 2013.

D. A. Grimes and K. F. Schulz, Bias and causal associations in observational research, Lancet, vol.359, issue.9302, pp.248-52, 2002.

P. R. Rosenbaum, Discussing hidden bias in observational studies, Ann Intern Med, vol.115, issue.11, pp.901-906, 1991.

M. Mehra, S. Desai, F. Ruschitzka, and A. Patel, Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, Lancet, 2020.

Z. Feng-cai, Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-inhuman trial, Lancet, 2020.

L. E. Thomas, R. O. Bonow, and M. J. Pencina, Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19), JAMA Cardiol, 2020.

E. L. Fosbøl, J. H. Butt, L. Østergaard, C. Andersson, C. Selmer et al., Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality, Jama, vol.2020, issue.2, pp.168-77

B. Cao, Y. Wang, D. Wen, W. Liu, J. Wang et al., A Trial of Lopinavir, N Engl J Med, vol.2020, issue.19, pp.1787-1799

I. F. Hung, K. C. Lung, E. Y. Tso, R. Liu, T. W. Chung et al.,

J. Chan, A. R. Tam, H. P. Shum, V. Chan, A. K. Wu et al., , p.19

J. W. Yan, W. W. Chan, J. F. Lie, A. K. Tsang, O. T. Cheng et al., Triple combination of interferon beta-1b, lopinavirritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, Lancet, 2020.

Y. Wang, Remdesivir in adults with severe COVID-19: a randomised, doubleblind, placebo-controlled, multicentre trial, Lancet, vol.395, pp.1569-1578, 2020.

J. Beigel, Remdesivir for the Treatment of Covid-19 -Preliminary Report, 2020.

J. D. Goldman, D. C. Lye, D. S. Hui, K. M. Marks, R. Bruno et al.,

H. Osinusi, A. O. Cao, H. Blair, C. Wei, X. Gaggar et al., Remdesivir for 5 or 10 Days in Patients with Severe Covid-19, N Engl J Med, 2020.

D. R. Boulware, M. F. Pullen, A. S. Bangdiwala, K. A. Pastick, and S. M. Lofgren,

E. C. Okafor, C. P. Skipper, A. A. Nascene, M. R. Nicol, M. Abassi et al.,

M. P. Labar, D. Lother, S. A. Mackenzie, L. J. Drobot, G. Marten et al., A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19, N Engl J Med, 2020.

L. Li, W. Zhang, Y. Hu, X. Tong, S. Zheng et al.,

H. Mei, C. Hu, C. Tao, R. Yang, J. Wang et al., Effect of Convalescent Plasma Therapy on Time to Clinical, p.20

, Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial, Jama, 2020.

P. Horby, W. S. Lim, J. R. Emberson, M. Mafham, J. L. Bell et al., Dexamethasone in Hospitalized Patients with Covid-19 -Preliminary Report, N Engl J Med, 2020.

A. V. Hernandez, Y. M. Roman, V. Pasupuleti, J. J. Barboza, and C. M. White, Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review, Ann Intern Med, 2020.

P. E. Alexander, V. B. Debono, M. J. Mammen, A. Iorio, K. Aryal et al.,

E. Brocard, W. Alhazzani, M. L. Dougan, and C. A. Sacks, COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine, J Clin Epidemiol, 2020.

, Covid-19 Era and Beyond, N Engl J Med, 2020.

H. C. Lane and A. S. Fauci, Research in the Context of a Pandemic, N Engl J Med, 2020.

J. W. Peabody, P. E. Farmer, and E. J. Rubin, An organizational analysis of the World Health Organization: narrowing the gap between promise and performance, N Engl J Med, vol.40, issue.6, 1995.

C. A. Devaux, J. M. Rolain, P. Colson, and D. Raoult, Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 -update #3, Int J Antimicrob Agents, 2020.

P. W. Armstrong and C. D. Naylor, Counteracting Health Misinformation: A Role for Medical Journals?, Jama, vol.2019, issue.19, pp.1863-1864

W. S. Chou, A. Oh, and W. M. Klein, Addressing Health-Related Misinformation on Social Media, Jama, vol.320, issue.23, pp.2417-2418, 2018.

R. M. Merchant and D. A. Asch, Protecting the Value of Medical Science in the Age of Social Media and "Fake News, Jama, vol.320, issue.23, pp.2415-2416, 2018.

S. Vosoughi, D. Roy, and S. Aral, The spread of true and false news online, Science, vol.359, issue.6380, pp.1146-1151, 2018.

S. Kumar and I. India, Hindu pride boosts pseudoscience, Science, vol.363, pp.679-680, 2019.

D. A. Broniatowski, A. M. Jamison, S. Qi, L. Alkulaib, T. Chen et al.,

S. C. Quinn and M. Dredze, Weaponized Health Communication: Twitter Bots and Russian Trolls Amplify the Vaccine Debate, Am J Public Health, vol.108, issue.10, pp.1378-1384, 2018.

R. P. Wenzel, Medical Education in the Era of Alternative Facts, N Engl J Med, vol.2017, issue.7, pp.607-609

A. Berezow, Infographic: The Best And Worst Science News Sites, 2017.

Y. Roth and A. Achuthan, Building rules in public: Our approach to synthetic & manipulated media, p.22

S. M. Fast, L. Kim, E. L. Cohn, S. R. Mekaru, J. S. Brownstein et al., Predicting social response to infectious disease outbreaks from internet-based news streams, United States, vol.263, issue.c, pp.551-564, 2017.

J. A. Hill, S. Agewall, A. Baranchuk, G. W. Booz, J. S. Borer et al.,

P. S. Dominiczak, A. F. Erol, C. Grines, C. L. Gropler, R. Guzik et al., Medical Misinformation: Vet the Message!, Eur Heart J, vol.40, issue.5, pp.404-405, 2019.

D. Atkins, D. Best, P. A. Briss, M. Eccles, Y. Falck-ytter et al.,

H. Harbour, R. T. Haugh, M. C. Henry, D. Hill, S. Jaeschke et al., Grading quality of evidence and strength of recommendations, Bmj, vol.328, issue.7454, 2004.

R. Thamman, M. Gulati, A. Narang, A. Utengen, M. A. Mamas et al., Twitter-based learning for continuing medical education?, Eur Heart J, 2020.

R. Thaler, C. Sunstein, N. J. Van-eck, L. Waltman, A. F. Van-raan et al., Citation analysis may severely underestimate the impact of clinical research as compared to basic research, PLoS One, vol.23, issue.4, p.62395, 2008.

, Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA

, Against Novel Coronavirus

, In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead

W. Haseltine, Rush to share good news on COVID-19 drugs is undermining science